abstract |
Disclosed herein are recombinant Listeria strains comprising nucleotides encoding two or more heterologous antigens, each of which is fused to a truncated LLO, N-terminal ActA or PEST sequence; A method of preparation; and a method of inducing an immune response, and treating, inhibiting or suppressing cancer or a tumor, the methods comprising administering the strains. |